Diagnosis and management of typical and atypical lung carcinoids
- 1 April 2016
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 100, 167-176
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Survival Benefits from Follow-Up of Patients with Lung Cancer: A Systematic Review and Meta-AnalysisJournal of Thoracic Oncology, 2011
- Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2011
- Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lungEndocrine-Related Cancer, 2010
- 90Y-Edotreotide for Metastatic Carcinoid Refractory to OctreotideJournal of Clinical Oncology, 2010
- Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumoursBritish Journal of Cancer, 2010
- Long-Term Follow-Up of Flexible Bronchoscopic Treatment for Bronchial Carcinoids with Curative IntentDiagnostic and Therapeutic Endoscopy, 2009
- O 6-Methylguanine DNA Methyltransferase Deficiency and Response to Temozolomide-Based Therapy in Patients with Neuroendocrine TumorsClinical Cancer Research, 2008
- Gastroenteropancreatic neuroendocrine tumoursThe Lancet Oncology, 2008
- Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?Cancer Chemotherapy and Pharmacology, 2006
- A 5‐decade analysis of 13,715 carcinoid tumorsCancer, 2003